The chart is not accessible to screen readers. Please switch to the table view to access the data.
Advertisement
Advertisement
Market share of the U.S. hyperimmunes market in 2016, by company
Hyperimmunes market share in U.S. by company 2016
This statistic shows the market share of the hyperimmunes market in the U.S. in 2016. Grifols had the largest hyperimmunes market share with some ** percent while Kedrion had the second largest market share with some ** percent.
Log in or register to access precise data.
* For commercial use only
Basic Account
For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
- Free Statistics
Based on your interests
Starter Account
For single users
$199 USD
per month, billed annually
1
- Free Statistics
- Premium Statistics
The statistic on this page is a Premium Statistic and is included in this account.
Professional Account
For teams of up to 99 users
Talk to sales for pricing
- Free + Premium Statistics
- Reports
- Market ÌÇÐÄÆƽâ°æ
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
Other statistics that may interest you Statistics on
About the industry
10
- Premium Statistic Grifols immunoglobulin monthly market share in the U.S. 2016-2017
- Premium Statistic IVIG global market share by company 2015
- Premium Statistic IV and SC immunoglobulin global market share 2015 by company
- Premium Statistic Albumin global market share by company 2016
- Premium Statistic Alpha-1 global market share by company 2016
- Basic Statistic Polyvalent immune globulin sales worldwide 1992-2026
- Basic Statistic Share of pharmaceutical value worldwide 2021, by country
- Basic Statistic U.S. and Europe biopharma company trade sales 2009 to 2019
- Premium Statistic US and European biopharma company M&A transaction volumes by type 2010-2019
- Basic Statistic Number of U.S. biopharma M&A deals 2015-2019, by transaction volume
About the region
10
- Premium Statistic Market share for medical and surgical hemostats U.S. 2015
- Basic Statistic Top essential health care services according to U.S. patients 2019
- Premium Statistic Revenue of the pharmaceutical company Bracco 2020, by geographical area
- Premium Statistic Largest M&A deals in cannabis industry in North America 2021
- Premium Statistic Pharmaceutical expenditure forecast worldwide by country 2030
- Basic Statistic Pharmaceutical sector expenditure forecast worldwide by country 2060
- Basic Statistic Pharmaceutical sector expenditures worldwide forecast by country 2017
- Basic Statistic U.S. adults' level of concern about influenza in 2022, by gender
- Basic Statistic U.S. adults' level of concern about measles in 2022, by generation
- Basic Statistic U.S. adults' level of concern about measles in 2022, by gender
Selected statistics
10
- Premium Statistic Average value of biopharma M&A deals worldwide 2010-2019, by industry
- Basic Statistic Revenue of Sobi 2009-2024
- Premium Statistic Value of biopharma M&A deals worldwide 2010-2019, by industry
- Basic Statistic Market capitalization change in key COVID-19 firms until end-May 2020
- Basic Statistic Number of biopharma M&A deals worldwide 2010-2019, by total transaction value
- Premium Statistic Number of biopharma M&A deals worldwide 2010-2019, by industry
- Basic Statistic Value share of pharmaceutical subsectors worldwide 2003 vs. 2021
- Premium Statistic Revenue from pharmaceutical manufacturer in Denmark 2009-2024
- Basic Statistic Average length of a clinical trial cycle 2020-2024
- Premium Statistic Number of biopharma M&A deals worldwide 2010-2019, by companies
Other regions
10
- Basic Statistic Global blood plasma market share 2017, by country
- Basic Statistic Value share of biotech sector worldwide 2021, by country
- Basic Statistic Top countries in global blood plasma market in 2017, by value
- Premium Statistic Share of global immunoglobulin therapies market 2017, by country
- Basic Statistic Per capita albumin consumption change 2012-2016, by country
- Premium Statistic Share of units sold of Rx oral solid opioids in U.S. 2017 by drug
- Basic Statistic US and European VC-backed oncology biopharma company M&A values 2010-2019
- Basic Statistic Number of startups using AI in drug discovery worldwide 2019, by area of discovery
- Basic Statistic Albumin consumption worldwide 1992-2026
- Premium Statistic US and European private VC-backed orphan biopharma company M&A values 2014-2019
Related statistics
10
- Basic Statistic Value share of biotech sector worldwide by therapeutic area 2021
- Basic Statistic Total value of pharmaceutical sector worldwide 2021, by major country
- Basic Statistic Top biopharmaceutical companies in cardiometabolic care worldwide 2020
- Basic Statistic Global volume of plasma produced for fractionation 1990-2018, by type
- Premium Statistic Expected growth in U.S. pharma profit 2019-2024 by drug type
- Premium Statistic Premiums for public U.S. biopharma company trade sales 2010-2019
- Basic Statistic Operating profit (EBIT) of Sobi 2009-2024
- Premium Statistic Total value of biopharma M&A deals worldwide from 2010 to 2019, by top companies
- Basic Statistic Drugs in development for selected autoimmune diseases U.S. 2016
- Basic Statistic Profit of Sobi 2009-2024
Further Content: You might find this interesting as well
* For commercial use only
Basic Account
For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
- Free Statistics
Based on your interests
Starter Account
For single users
$199 USD
per month, billed annually
1
- Free Statistics
- Premium Statistics
The statistic on this page is a Premium Statistic and is included in this account.
Professional Account
For teams of up to 99 users
Talk to sales for pricing
- Free + Premium Statistics
- Reports
- Market ÌÇÐÄÆƽâ°æ
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
Grifols. (June 7, 2017). Market share of the U.S. hyperimmunes market in 2016, by company [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 24, 2026, from /statistics/758043/hyperimmunes-market-share-in-us-by-company/
Grifols. "Market share of the U.S. hyperimmunes market in 2016, by company." Chart. June 7, 2017. ÌÇÐÄÆƽâ°æ. Accessed July 24, 2026. /statistics/758043/hyperimmunes-market-share-in-us-by-company/
Grifols. (2017). Market share of the U.S. hyperimmunes market in 2016, by company. ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 24, 2026. /statistics/758043/hyperimmunes-market-share-in-us-by-company/
Grifols. "Market Share of The U.S. Hyperimmunes Market in 2016, by Company." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 7 Jun 2017, /statistics/758043/hyperimmunes-market-share-in-us-by-company/
Grifols, Market share of the U.S. hyperimmunes market in 2016, by company ÌÇÐÄÆƽâ°æ, /statistics/758043/hyperimmunes-market-share-in-us-by-company/ (last visited July 24, 2026)
Market share of the U.S. hyperimmunes market in 2016, by company [Graph], Grifols, June 7, 2017. [Online]. Available: /statistics/758043/hyperimmunes-market-share-in-us-by-company/
Advertisement